07.01.05
Sabinsa Corporation, Piscataway, NJ, has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company’s ForsLean brand Coleus forskohlii extract, as a dietary supplement for the purpose of promoting lean body mass, shifting the proportion of mass in favor of lean body mass, reducing fat tissue and encouraging weight loss. The European patent #989075379 encompasses all European countries and Sabinsa intends to make the use of these claims, along with the use of the patent number, available to dietary supplement manufacturers and marketers in Europe through a non-exclusive licensing agreement.